Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics

Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of...

Full description

Saved in:
Bibliographic Details
Published inNeurotherapeutics Vol. 14; no. 4; pp. 945 - 951
Main Authors Amezcua, Lilyana, Nelson, Flavia
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.10.2017
Springer US
Springer Nature B.V
Subjects
Biomedical and Life Sciences
Biomedicine
Ethics
Humans
Medical ethics
Multiple sclerosis
Multiple Sclerosis - economics
Multiple Sclerosis - therapy
Naltrexone
Neurobiology
Neurology
Neurosciences
Neurosurgery
Patient Participation
Patient-funded research
Review
Reviews
Stem cells
Translational Research, Biomedical - economics
Translational Research, Biomedical - ethics
Ethics
Multiple sclerosis
Patient-funded research
Online AccessGet full text
ISSN1878-7479
1933-7213
1878-7479
DOI10.1007/s13311-017-0560-9

Cover

More Information
Summary:Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
ISSN:1878-7479
1933-7213
1878-7479
DOI:10.1007/s13311-017-0560-9